Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced the European Medicines Agency's Committee for Medicinal Products for Hu
Cooper-Standard's revenue growth has stabilized at 2.2% YoY, but this masks a fundamentally challenged business with persistent net losses and a structurally insolvent balance sheet. The company's negative equity of $130.6 million and $1.2 billion in debt crea...
Price trend, volume and key moving averages
Trailing total returns as of 9/24/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC).
Check whether operating performance supports the current valuation.
Recent results and news deserve attention only when they alter the forward view.
| Quarter | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|
Q3 2026Latest Aug 5, 2026 | -$0.13-123.9% vs $0.54 | $721M+1.8% vs $709M |
Q2 2026 May 6, 2026 | -$0.29-81.3% vs -$0.16 | $686M+4.0% vs $660M |
Q1 2026 Feb 12, 2026 | -$1.73-82.1% vs -$0.95 | $672M+4.8% vs $641M |
Q4 2025 Oct 30, 2025 | -$0.24-148.0% vs $0.50 | $696M+4.2% vs $668M |
Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced the European Medicines Agency's Committee for Medicinal Products for Hu
[url="]Elastic[/url] (NYSE: ESTC) today announced the general availability of cross-project search (CPS) for Elastic Cloud Serverless, enabling teams to query a
NORTHVILLE, Mich., Sept. 10, 2026 /PRNewswire/ -- Cooper Standard's (NYSE: CPS) El Jarudo manufacturing facility in Juárez, Chihuahua, Mexico, has earned recognition for manufacturing excellence as one of four winners of IndustryWeek's 2026 Best Plants Awards.
NORTHVILLE, Mich., Sept. 2, 2026 /PRNewswire/ -- Cooper Standard (NYSE: CPS), a leading global supplier of sealing and fluid handling systems and components, today announced that the Science-Based Targets initiative (SBTi) has validated Cooper Standard's near-term science-based emissions reduction targets.
Benchmark CPS against direct peers instead of judging its metrics in isolation.
Key metrics vs top competitors for Cooper-Standard Holdings Inc. (CPS)
| Company | Price | Market Cap | P/E Ratio | Rev Growth (1Y) | Net Margin | ROE | Div Yield |
|---|---|---|---|---|---|---|---|
| $23.01 | $408.55M | -100.04 | 0.37% | -0.15% | — | — | |
| $37.31 | $830.64M | 20.28 | 22.36% | 2.78% | 7.21% | — | |
| $66.98 | $279.9M | 14.62 | 5.08% | 3.56% | 7.84% | — | |
| $35.25 | $1.08B | 58.75 | 2.64% | 1.69% | 3.69% | — | |
| $11.54 | $266.72M | 6.48 | 25.18% | 10.38% | 7.11% | — | |
| $114.59 | $9.5B | 15.63 | -6.67% | 14.31% | 27.88% | — |
Cooper-Standard Holdings Inc. (CPS) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
Verify the primary filings, follow material updates, and answer the remaining questions.
Cooper-Standard Holdings Inc. (CPS) SEC filings — annual & quarterly reports (10-K, 10-Q)
Aug 6, 2026·SEC
May 15, 2026·SEC
May 7, 2026·SEC
Get notified when CPS posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
Cooper-Standard Holdings Inc. (CPS) stock FAQ — growth, dividends, profitability & financials explained
Cooper-Standard Holdings Inc. (CPS) reported $2.78B in revenue for fiscal year 2025. This represents a 52% increase from $1.83B in 2005.
Cooper-Standard Holdings Inc. (CPS) grew revenue by 0.4% over the past year. Growth has been modest.
Cooper-Standard Holdings Inc. (CPS) reported a net loss of $56.5M for fiscal year 2025.
Cooper-Standard Holdings Inc. (CPS) had negative free cash flow of $98.1M in fiscal year 2025, likely due to heavy capital investments.